Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil
ChAdOx1 nCoV-19 (AZD1222) 作为同源第四剂加强针的免疫原性和安全性：巴西 3 期 COV003 试验的子研究
期刊:Mayo Clinic Proceedings Innovations Quality Outcomes
影响因子:
doi:10.1016/j.mayocpiqo.2025.100642
Costa Clemens, Sue Ann; Bibi, Sagida; Marchevsky, Natalie G; Aley, Parvinder K; Cappuccini, Federica; Davies, Sophie A; Gonzalez, Isabela; Kelly, Sarah C; Mujadidi, Yama F; Pipolo Milan, Eveline; Schwarzbold, Alexandre V; Sprinz, Eduardo; Voysey, Merryn; Weckx, Lily Y; Wright, Daniel; Bansal, Himanshu; Bergagård, Maria A S; Isaacs, Abby J; Kelly, Elizabeth J; Lan, Dongmei; Morgan, Shethah; Shankar, Nirmal Kumar; Shoemaker, Kathryn; Villafana, Tonya L; Lambe, Teresa; Green, Justin A; Pollard, Andrew J
